FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation
June 27 2022 - 8:31AM
Business Wire
Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”)
(NASDAQ: BIOX), a fully integrated provider of crop productivity
solutions designed to enable the transition of agriculture towards
carbon neutrality, announced today that the U.S. Food and Drug
Administration (FDA) has concluded its evaluation of the Company´s
proprietary drought-tolerant HB4® Wheat.
Upon review of all the safety and regulatory information
submitted, the FDA has concluded that it has no further questions
regarding the safety of HB4® Wheat, and that it does not raise
issues that would require premarket review or approval by FDA. The
conclusion of this voluntary consultation program is a key step
towards commercial enablement in the United States, which is
awaiting approval from the U.S. Department of Agriculture
(USDA).
The United States is the fifth largest wheat producer, with an
average of 15 million hectares planted every year, and the third
largest exporter, holding a key position in the global wheat trade.
The FDA's conclusion follows recent approvals by Brazil, Colombia,
Australia, and New Zealand for use in food and feed. HB4® Wheat is
commercially authorized for production and consumption in
Argentina, where five varieties have been cleared for registration
in the current crop season.
HB4® drought-tolerance technology has been shown to increase
wheat yields by an average of 20% in water-limited conditions, a
key adaptation that favors double-cropping systems, where water
management is increasingly critical. Under no-till practices, HB4®
Soy-Wheat rotations result in an estimated 1,650 kg of carbon fixed
into the soil per hectare per year, compared to positive emissions
from conventional soy monoculture.
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully
integrated provider of crop productivity technologies designed to
enable the transition of agriculture towards carbon neutrality. To
do this, Bioceres’ solutions create economic incentives for farmers
and other stakeholders to adopt environmentally friendlier
production practices. The Company has a unique biotech platform
with high-impact, patented technologies for seeds and microbial
ag-inputs, as well as next generation crop nutrition and protection
solutions. Through its HB4® program, the Company is bringing
digital solutions to support growers’ decisions and provide
end-to-end traceability for production outputs. For more
information, visit here.
Forward-looking statements
This communication includes “forward-looking statements” within
the meaning of the “safe harbor” provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as
“forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,”
“expect,” “estimate,” “plan,” “outlook,” and “project” and other
similar expressions that predict or indicate future events or
trends or that are not statements of historical matters. Such
forward-looking statements are based on management’s reasonable
current assumptions, expectations, plans and forecasts regarding
the Company’s current or future results and future business and
economic conditions more generally. Such forward-looking statements
involve risks, uncertainties and other factors, which may cause the
actual results, levels of activity, performance or achievement of
the Company to be materially different from any future results
expressed or implied by such forward-looking statements, and there
can be no assurance that actual results will not differ materially
from management’s expectations or could affect the Company’s
ability to achieve its strategic goals, including the uncertainties
relating to the impact of COVID-19 on the Company’s business,
operations, liquidity and financial results and the other factors
that are described in the sections entitled “Risk Factors” in the
Company's Securities and Exchange Commission filings updated from
time to time. The preceding list is not intended to be an
exhaustive list of all of our forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements as predictions of future events. All forward-looking
statements contained in this release are qualified in their
entirety by this cautionary statement. Forward-looking statements
speak only as of the date they are or were made, and the Company
does not intend to update or otherwise revise the forward-looking
statements to reflect events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events,
except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220627005237/en/
Investor Relations Contact Chris Tyson Executive Vice
President MZ Group – MZ North America (949) 491-8235
BIOX@mzgroup.us www.mzgroup.us
Bioceres Crop Solutions Paula Savanti Head of Investor
Relations investorrelations@biocerescrops.com
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jul 2023 to Jul 2024